Sökning: onr:"swepub:oai:gup.ub.gu.se/144472" > Timing of radiother...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03337naa a2200901 4500 | |
001 | oai:gup.ub.gu.se/144472 | |
003 | SwePub | |
008 | 240410s2011 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/1444722 URI |
024 | 7 | a https://doi.org/10.1016/j.ijrobp.2010.02.0422 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Karlsson, Per,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xkperd |
245 | 1 0 | a Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy. |
264 | 1 | b Elsevier BV,c 2011 |
520 | a To evaluate the association between the interval from breast-conserving surgery (BCS) to radiotherapy (RT) and the clinical outcome among patients treated with adjuvant endocrine therapy. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Age Factors | |
653 | a Antineoplastic Agents | |
653 | a Hormonal | |
653 | a therapeutic use | |
653 | a Antineoplastic Combined Chemotherapy Protocols | |
653 | a administration & dosage | |
653 | a therapeutic use | |
653 | a Breast Neoplasms | |
653 | a chemistry | |
653 | a drug therapy | |
653 | a mortality | |
653 | a prevention & control | |
653 | a radiotherapy | |
653 | a surgery | |
653 | a Chemotherapy | |
653 | a Adjuvant | |
653 | a methods | |
653 | a Combined Modality Therapy | |
653 | a methods | |
653 | a Cyclophosphamide | |
653 | a administration & dosage | |
653 | a Disease-Free Survival | |
653 | a Female | |
653 | a Fluorouracil | |
653 | a administration & dosage | |
653 | a Humans | |
653 | a Mastectomy | |
653 | a Segmental | |
653 | a Menopause | |
653 | a Methotrexate | |
653 | a administration & dosage | |
653 | a Middle Aged | |
653 | a Neoplasm Recurrence | |
653 | a Local | |
653 | a prevention & control | |
653 | a Proportional Hazards Models | |
653 | a Receptors | |
653 | a Estrogen | |
653 | a analysis | |
653 | a Regression Analysis | |
653 | a Tamoxifen | |
653 | a therapeutic use | |
653 | a Time Factors | |
700 | 1 | a Cole, Bernard F4 aut |
700 | 1 | a Colleoni, Marco4 aut |
700 | 1 | a Roncadin, Mario4 aut |
700 | 1 | a Chua, Boon H4 aut |
700 | 1 | a Murray, Elizabeth4 aut |
700 | 1 | a Price, Karen N4 aut |
700 | 1 | a Castiglione-Gertsch, Monica4 aut |
700 | 1 | a Goldhirsch, Aron4 aut |
700 | 1 | a Gruber, Günther4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för onkologi4 org |
773 | 0 | t International journal of radiation oncology, biology, physicsd : Elsevier BVg 80:2, s. 398-402q 80:2<398-402x 1879-355Xx 0360-3016 |
856 | 4 | u https://europepmc.org/articles/pmc2992081?pdf=render |
856 | 4 8 | u https://gup.ub.gu.se/publication/144472 |
856 | 4 8 | u https://doi.org/10.1016/j.ijrobp.2010.02.042 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy